semaglutide and ibd

semaglutide and ibd Pharmacological interventions for obesity in patients with inflammatory bowel disease: A systematic review of GLP-1 receptor agonist efficacy safety semaglutide ibd Gut microbiota perturbation

Name: semaglutide and ibd Pharmacological interventions for obesity in patients with inflammatory bowel disease: A systematic review of GLP-1 receptor agonist efficacy safety semaglutide ibd Gut microbiota perturbation
Brand: actil.am
SKU: 13318911893
Price: 29.92 USD
Availability: InStock
Rating: 4.0297 (21 reviews)

SKU: 13318911893

4.0

USD29.92 USD55.92

Pay in 4 interest-free payments of $7.48 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 29 - Sep 3

Description

By balancing the potential benefits and risks of treatment using evidence-based strategies, HCPs are well placed to help optimise the use of GLP-1 RAs in the management of obesity and overweight